The people who work at Isis are committed to developing new medicines that improve patients’ lives. The Company is conducting a variety of clinical trials to advance the development of its antisense drug candidates towards commercialization. Through these clinical trials, the Company hopes to generate data that will support the marketing approval of its drugs. Isis is grateful to the dedicated patients who participate in these trials, and to their families and friends who support them. Together, there is an opportunity to offer hope to people with illnesses.

In this section, you will find information about enrolling clinical trials. For insight into all ongoing and historical studies of Isis’ antisense drugs, please visit the product pipeline section of this web site.



If you need information about a trial or want to enroll in a trial, please visit www.clinicaltrials.gov.  This government-sponsored website lists most ongoing trials including those for which enrollment is currently taking place.  Information is searchable by company, by drug candidate, by specific indication and by disease area.  For each trial, the investigator is named and enrollment information is provided if appropriate.

Information can also be obtained by leaving a message on the following Isis toll-free number: 1-800-679-ISIS (4747), or by sending us an e-mail at trialinfo@isisph.com.  These latter two channels are most appropriate if you'd like to speak with one of our clinical operations professionals about qualifying as a site or about supplying external services and support for clinical trials.